Literature DB >> 20012668

Colorectal cancer in Turkey: current situation and challenges for the future.

Mehtap Tatar1, Fahreddin Tatar.   

Abstract

Cancer is foremost among one of the major public health problems in Turkey. Projections for the year 2030 estimate that cancer will take the highest death toll for both males and females. In line with the dynamic health care reform process commencing in 2003, the national cancer policy of Turkey has also changed radically. Cancer became more visible as a public health problem and improvements have been made in early diagnosis and treatment of the disease. In addition, major steps have been taken to improve the cancer registry system in order to improve cancer statistics. Colorectal cancer (CRC) incidence is approximately 7 per 100,000, with approximately 5,000 new cases and 3,200 deaths annually. Although cancer treatment expenditures are widely covered in Turkey, there are still problems related to the general accessibility of the health care system. This paper addresses the case of cancer in Turkey with special focus on CRC. Specifically, detailed information is provided about the health care and cancer policies, improvements since 2003 and challenges for the future.

Entities:  

Mesh:

Year:  2010        PMID: 20012668     DOI: 10.1007/s10198-009-0197-7

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  4 in total

1.  Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries.

Authors:  Annie O Chan; Amr S Soliman; Qing Zhang; Asif Rashid; Ahmed Bedeir; P Scott Houlihan; Nadia Mokhtar; Nidal Al-Masri; Ugur Ozbek; Rami Yaghan; Ayten Kandilci; Sherif Omar; Yersu Kapran; Ferhunde Dizdaroglu; Melissa L Bondy; Christopher I Amos; Jean-Pierre Issa; Bernard Levin; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

2.  Estimating mortality and causes of death in Turkey: methods, results and policy implications.

Authors:  Seval Akgün; Chalapati Rao; Nazan Yardim; Berrak Bora Basara; Ozlem Aydin; Salih Mollahaliloglu; Alan D Lopez
Journal:  Eur J Public Health       Date:  2007-04-02       Impact factor: 3.367

3.  Complementary and alternative medicine use in lung cancer patients in eight European countries.

Authors:  Alexander Molassiotis; Vassiliki Panteli; Elisabeth Patiraki; Gulten Ozden; Nurgun Platin; Elin Madsen; Maria Browall; Paz Fernandez-Ortega; Dorit Pud; Anita Margulies
Journal:  Complement Ther Clin Pract       Date:  2005-11-14       Impact factor: 2.446

4.  The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.

Authors:  Lale A Algier; Ziyafet Hanoglu; Gülten Ozden; Figen Kara
Journal:  Eur J Oncol Nurs       Date:  2005-06       Impact factor: 2.398

  4 in total
  11 in total

1.  The effect of polymorphism in DNA repair genes RAD51 and XRCC2 in colorectal cancer in Turkish population.

Authors:  Suleyman Cetinkunar; Ilhami Gok; Ruchan Bahadir Celep; Dogan Ilhan; Hasan Erdem; Bulent Caglar Bilgin; Recep Aktimur
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  The dynamics of colorectal cancer management in 17 countries.

Authors:  Panos Kanavos; Willemien Schurer
Journal:  Eur J Health Econ       Date:  2010-01

3.  Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.

Authors:  Atilla Engin; Ipek Isik Gonul; Ayse Basak Engin; Ahmet Karamercan; Aylin Sepici Dincel; Ayse Dursun
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

4.  Investigation of Isolated Blastocystis Subtypes from Cancer Patients in Turkey.

Authors:  Sefa Mülayim; Mehmet Aykur; Hande Dağcı; Semih Dalkılıç; Asude Aksoy; Mustafa Kaplan
Journal:  Acta Parasitol       Date:  2021-01-02       Impact factor: 1.440

Review 5.  Colorectal cancer screening in countries of European Council outside of the EU-28.

Authors:  Emma Altobelli; Francesco D'Aloisio; Paolo Matteo Angeletti
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

6.  Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.

Authors:  Celalettin Camci; Akif Sahin; Alper Sevinc; Mehmet E Kalender; Serdar Oztuzcu; Ozlem N Sever; Esma Ozkara; Abdullah T Demiryürek
Journal:  Tumour Biol       Date:  2011-09-08

7.  Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

Authors:  Iva Kirac; Mario Sekerija; Iva Simunović; Lina Zgaga; Danko Velimir Vrdoljak; Dujo Kovacević; Tomislav Kulis; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

Review 8.  Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Iraj Asvadi Kermani; Morteza Ghojazadeh; Mohamad Asghari Jafarabadi; Faris Farassati; Saeed Dastgiri
Journal:  BMC Public Health       Date:  2015-10-01       Impact factor: 3.295

9.  Scrotal skin metastasis from rectum adenocarcinoma.

Authors:  Aytul Ozgen; Ebru Karakaya; Nazan Bozdoğan
Journal:  Rare Tumors       Date:  2013-12-05

10.  The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review.

Authors:  Désirée Schliemann; Kogila Ramanathan; Nicholas Matovu; Ciaran O'Neill; Frank Kee; Tin Tin Su; Michael Donnelly
Journal:  BMC Cancer       Date:  2021-10-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.